Azenta, Inc. (NASDAQ:AZTA) Stock Position Lowered by State of Alaska Department of Revenue

State of Alaska Department of Revenue cut its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 6.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,689 shares of the company’s stock after selling 360 shares during the period. State of Alaska Department of Revenue’s holdings in Azenta were worth $275,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Azenta by 1.9% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after purchasing an additional 100,826 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Azenta by 16.5% during the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after purchasing an additional 421,719 shares during the period. Allspring Global Investments Holdings LLC raised its position in shares of Azenta by 16.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock worth $62,917,000 after purchasing an additional 183,040 shares during the period. Bank of New York Mellon Corp raised its position in shares of Azenta by 3.8% during the second quarter. Bank of New York Mellon Corp now owns 515,393 shares of the company’s stock worth $27,120,000 after purchasing an additional 18,680 shares during the period. Finally, Federated Hermes Inc. raised its position in shares of Azenta by 6.3% during the second quarter. Federated Hermes Inc. now owns 432,506 shares of the company’s stock worth $22,758,000 after purchasing an additional 25,586 shares during the period. 99.08% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AZTA has been the topic of a number of recent analyst reports. Needham & Company LLC reaffirmed a “buy” rating and set a $69.00 target price on shares of Azenta in a research report on Wednesday, August 7th. Evercore ISI dropped their price target on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $66.40.

Insider Buying and Selling at Azenta

In other Azenta news, CFO Herman Cueto sold 1,595 shares of the business’s stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $43.68, for a total value of $69,669.60. Following the transaction, the chief financial officer now owns 24,604 shares in the company, valued at $1,074,702.72. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.77% of the company’s stock.

Azenta Trading Down 1.6 %

NASDAQ:AZTA opened at $44.78 on Friday. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of -15.94 and a beta of 1.48. Azenta, Inc. has a 1-year low of $40.24 and a 1-year high of $69.16. The business’s fifty day moving average price is $45.94 and its 200 day moving average price is $50.73.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.